MCRB Seres Therapeutics, Inc.

$6.60 +3.61%

Healthcare · Pharmaceutical Preparations

Seres Therapeutics, Inc. (MCRB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $63 million. Shares last traded at $6.60, 78.5% below their 52-week high. Over the past year the stock is down 10.0%. MCRB trades at a price-to-earnings ratio of 11.11, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 721.9%, above the peer median of -0.1%.

Market Cap

$63M

Shares Out

9.6M

EPS (TTM)

$5.54

P/E Ratio

1.19

P/S Ratio

80.24

P/B Ratio

2.39

Dividend / Share

—

Dividend Yield

—

52-Week High

$30.69

52-Week Low

$5.32

Volume

4,146

Avg Vol (3m)

1,995.81

Performance

+4.60%

-11.53%

-26.26%

-59.18%

YTD

-56.26%

-10.02%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.45

SMA (50)

$7.54

SMA (200)

$13.07

Price vs SMA50

-12.42%

Price vs SMA200

-49.49%

ATR (14)

$0.55

Financials

Revenue

$1M

Net Income

$6M

Gross Margin

—

Operating Margin

-11910.1%

Net Margin

721.9%

Return on Equity

21.5%

Return on Assets

4.8%

Current Ratio

1.65

Debt / Equity

4.15

Revenue Growth (YoY)

—

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-2.08	2026-05-05
FY 2025	$0.64	2026-03-12
Q3 2025	$2.40	2025-11-05
Q2 2025	$1.47	2025-08-06
Q1 2026	$3.75	2026-05-05
FY 2025	$0.00	2026-03-12

Full earnings history →

Pharmaceutical Preparations peers

MCRB vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

11.11 / 16.82 med

-34% discount

P/S vs peers

80.24 / 3.54 med

+2168% premium

Net margin vs peers

721.9% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.